Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 873-878

  Emoto, Masanori ^a   Mori, Katsuhito ^a   Lee, Eiko ^a   Kawano, Naoya ^a   Yamazaki, Yuko ^a   Tsuchikura, Shoko ^a   Morioka, Tomoaki ^a   Koyama, Hidenori ^a   Shoji, Tetsuo ^a   Inaba, Masaaki ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A;

AGED; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; DIABETIC PATIENT; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

AGED; ALPHA-FETOPROTEINS; ATHEROSCLEROSIS; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FEMORAL ARTERY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RENAL DIALYSIS;

EID: 77952252972     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.005     Document Type: Article

References (30)

1. Ketteler M., Westenfeld R., Schlieper G., and Brandenburg V. Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol 9 (2005) 265-270
2. Ketteler M. Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 14 (2005) 337-342
3. Schinke T., Amendt C., Trindl A., Poschke O., Muller-Esterl W., and Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271 (1996) 20789-20796
4. Schafer C., Heiss A., Schwarz A., et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112 (2003) 357-366
5. Ketteler M., Bongartz P., Westenfeld R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361 (2003) 827-833
6. Wang A.Y., Woo J., Lam C.W., et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20 (2005) 1676-1685
7. Stenvinkel P., Wang K., Qureshi A.R., et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67 (2005) 2383-2392
8. Hermans M.M., Brandenburg V., Ketteler M., et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72 (2007) 202-207
9. Zheng S., de Las Fuentes L., Bierhals A., et al. Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. Am J Cardiol 103 (2009) 46-49
10. Mehrotra R., Westenfeld R., Christenson P., et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67 (2005) 1070-1077
11. Mikami S., Hamano T., Fujii N., et al. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res 31 (2008) 1163-1170
12. Roos M., Lutz J., Salmhofer H., et al. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 68 (2008) 660-665
13. Lehtinen A.B., Burdon K.P., Lewis J.P., et al. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 92 (2007) 345-352
14. Floege J., and Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 19 Suppl 5 (2004) V59-V66
15. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
16. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S5-S10
17. Mori K., Emoto M., Yokoyama H., et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29 (2006) 468
18. Mori K., Emoto M., Araki T., et al. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 66 (2007) 246-250
19. Mori K., Emoto M., Araki T., et al. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism 57 (2008) 1248-1252
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Emoto M., Nishizawa Y., Kawagishi T., et al. Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 21 (1998) 1178-1182
22. Koyama H., Maeno T., Fukumoto S., et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 108 (2003) 524-529
23. Lee E., Emoto M., Teramura M., et al. The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes. J Atheroscler Thromb 16 (2009) 33-39
24. Westenfeld R., Schafer C., Kruger T., et al. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 20 (2009) 1264-1274
25. Ix J.H., Chertow G.M., Shlipak M.G., Brandenburg V.M., Ketteler M., and Whooley M.A. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115 (2007) 2533-2539
26. Koos R., Brandenburg V., Mahnken A.H., et al. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. Eur Heart J (2009)
27. Simon A., Chironi G., and Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension 48 (2006) 392-396
28. Jahnen-Dechent W., Schafer C., Ketteler M., and McKee M.D. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 86 (2008) 379-389
29. Price P.A., Thomas G.R., Pardini A.W., Figueira W.F., Caputo J.M., and Williamson M.K. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277 (2002) 3926-3934
30. Matsui I., Hamano T., Mikami S., et al. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 75 (2009) 915-928